New stent aims to tackle tough heart blockages

NCT ID NCT05658250

Ongoing Disease control Sponsor: Yonsei University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a special drug-coated stent called Cre8 in 300 people with long blockages (at least 30 mm) in their heart arteries. The stent releases a medicine to help keep the artery open. Researchers are watching to see if it is safe and effective, looking for problems like heart attacks or the need for another procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CRE8 polymer-free amphilimus-eluting stent
What this could lead to: If successful, this could offer a better treatment option for people with long blockages in heart arteries, potentially reducing the need for repeat procedures.
What could go wrong: This is an observational study, not a randomized trial, so results may be less definitive. The stent may still carry risks like blood clots or re-narrowing of the artery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE DRUG-ELUTING STENT

Contacts and locations

Locations

Yongin Severance Hospital

Yongin, Gyeonggi-do, 16995, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.